Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 2, 2010, Pages 191-196

  Chen, S H ^a,b   Pei, D ^a   Yang, W ^a   Cheng, C ^a   Jeha, S ^a   Cox, N J ^c   Evans, W E ^a,d   Pui, C H ^a,d   Relling, M V ^a,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR GRIA1; MERCAPTOPURINE; METHOTREXATE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLERGIC REACTION; ARTICLE; ASPARAGINASE HYPERSENSITIVITY; CHILD; CHROMOSOME 5Q; CLINICAL FEATURE; COHORT ANALYSIS; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SWELLING; TACHYPNEA; URTICARIA; WHEEZING;

ADOLESCENT; ALLELES; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 5; COHORT STUDIES; DNA; DRUG HYPERSENSITIVITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MICRONUCLEUS, GERMLINE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, AMPA; REPRODUCIBILITY OF RESULTS; RISK;

EID: 77954886794     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.94     Document Type: Article

References (51)

1. Pui C.H. & Evans W.E. treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354 166-178 (2006).
2. Pui, C.H. & Jeha, S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat. Rev. Drug Discov. 6, 149-165 (2007).
3. Schrappe, M. et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. german-Austrian-swiss ALL-BFM study group. Blood 95, 3310-3322 (2000).
4. Haskell, C.M. & Canellos, G.P. l-Asparaginase resistance in human leukemia-asparagine synthetase. Biochem. Pharmacol. 18, 2578-2580 (1969).
5. Cheung, N.K., Chau, I.Y. & Coccia, P.F. Antibody response to Escherichia coli L-asparaginase. Prognostic signifcance and clinical utility of antibody measurement. Am. J. Pediatr. Hematol. Oncol. 8, 99-104 (1986).
6. Jafe, N. et al. L-Asparaginase in the treatment of neoplastic diseases in children. Cancer Res. 31, 942-949 (1971).
7. Jafe, N. et al. Favorable remission induction rate with twice weekly doses of l-asparaginase. Cancer Res. 33, 1-4 (1973).
8. Killander, D. et al. Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer 37, 220-228 (1976).
9. Leventhal, B.G. & Henderson, E.S. therapy of acute leukemia with drug combinations which include asparaginase. Cancer 28, 825-829 (1971).
10. Nesbit, M., Chard, R., Evans, A., Karon, M. & Hammond, G.D. Evaluation of intramuscular versus intravenous administration of l-asparaginase in childhood leukemia. Am. J. Pediatr. Hematol. Oncol. 1, 9-13 (1979).
11. Oettgen, H.F. et al. toxicity of E. coli L-asparaginase in man. Cancer 25, 253-278 (1970).
12. Pratt, C.B., simone, J.V., Zee, P., Aur, R.J. & Johnson, W.W. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. J. Pediatr. 77, 474-483 (1970).
13. Pratt, C.B., Choi, S.I. & Holton, C.P. Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia. Am. J. Dis. Child. 121, 406-409 (1971).
14. Woo, M.H. et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J. Clin. Oncol. 18, 1525-1532 (2000).
15. Evans, W.E. et al. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer 49, 1378-1383 (1982).
16. Land, V.J., sutow, W.W., Fernbach, D.J., Lane, D.M. & Williams, T.E. toxicity of l-asparginase in children with advanced leukemia. Cancer 30, 339-347 (1972).
17. Jacquillat, C. et al. treatment of acute leukemia with l-asparaginase-preliminary results on 84 cases. Recent Results Cancer Res. 33, 263-278 (1970).
18. Asselin, B.L., Whitin, J.C., Coppola, D.J., Rupp, I.P., sallan, S.E. & Cohen, H.J. Comparative pharmacokinetic studies of three asparaginase preparations. J. Clin. Oncol. 11, 1780-1786 (1993)
19. Peterson, R.G., Handschumacher, R.E. & Mitchell, M.S. Immunological responses to l-asparaginase. J. Clin. Invest. 50, 1080-1090 (1971).
20. Bugelski, P.J. genetic aspects of immune-mediated adverse drug efects. Nat. Rev. Drug Discov. 4, 59-69 (2005).
21. Alfrevic, A. et al. serious carbamazepine-induced hypersensitivity reactions associated with the HsP70 gene cluster. Pharmacogenet. Genomics 16, 287-296 (2006).
22. Mallal, S. et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359, 727-732 (2002)
23. Mallal, S. et al. HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568-579 (2008).
24. Martin, A.M. et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl. Acad. Sci. U.S.A. 101, 4180-4185 (2004).
25. Beyer, K. et al. Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J. Invest. Dermatol. 115, 906-908 (2000).
26. Blumenthal, M.N. et al. A genome-wide search for allergic response (atopy) genes in three ethnic groups: Collaborative study on the genetics of Asthma. Hum. Genet. 114, 157-164 (2004).
27. Hizawa, N. et al. genetic infuences of chromosomes 5q31-q33 and 11q13 on specifc IgE responsiveness to common inhaled allergens among African American families. Collaborative study on the genetics of Asthma (CsgA). J. Allergy Clin. Immunol. 102, 449-453 (1998).
28. Koppelman, G.H. et al. genome-wide search for atopy susceptibility genes in Dutch families with asthma. J. Allergy Clin. Immunol. 109 498-506 (2002).
29. Noguchi, E. et al. Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population. Am. J. Respir. Crit. Care Med. 156, 1390-1393 (1997).
30. Xu, J. et al. genomewide screen and identifcation of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am. J. Hum. Genet. 68, 1437-1446 (2001).
31. Vandebriel, R.J. gene polymorphisms within the immune system that may underlie drug allergy. Naunyn Schmiedebergs Arch. Pharmacol. 369, 125-132 (2004).
32. Kerner, B., Jasinska, A.J., DeYoung, J., Almonte, M., Choi, O.W. & Freimer, N.B. Polymorphisms in the gRIA1 gene region in psychotic bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 24-32 (2009).
33. Magri, C. et al. glutamate AMPA receptor subunit 1 gene (gRIA1) and DsM-IV-tR schizophrenia: a pilot case-control association study in an Italian sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 287-293 (2006).
34. Egebjerg, J., Kukekov, V. & Heinemann, S.F. Intron sequence directs RNA editing of the glutamate receptor subunit gluR2 coding sequence. Proc. Natl. Acad. Sci. USA 91, 10270-10274 (1994).
35. Franco, R., Pacheco, R., Lluis, C., Ahern, G.P. & O'Connell, P.J. the emergence of neurotransmitters as immune modulators. Trends Immunol. 28, 400-407 (2007).
36. Pacheco, R., gallart, T., Lluis, C. & Franco, R. Role of glutamate on t-cell mediated immunity. J. Neuroimmunol. 185, 9-19 (2007).
37. Wacker, P. et al. Allergic reactions to E. coli l-asparaginase do not afect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology group study. J. Pediatr. Hematol. Oncol. 29, 627-632 (2007).
38. Hughes, A.R. et al. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 5, 203-211 (2004)
39. Saag, M. et al. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confrmed abacavir hypersensitivity in white and black patients. Clin. Infect. Dis. 46, 1111-1118 (2008).
40. McDaniel, M., Paxson, C. & Waldfogel, J. Racial disparities in childhood asthma in the United states: evidence from the National Health Interview survey, 1997 to 2003. Pediatrics 117, e868-e877 (2006).
41. Lara, M., Akinbami, L., Flores, G. & Morgenstern, H. Heterogeneity of childhood asthma among Hispanic children: Puerto Rican children bear a disproportionate burden. Pediatrics 117, 43-53 (2006).
42. Brim, S.N., Rudd, R.A., Funk, R.H. & Callahan, D.B. Asthma prevalence among Us children in underrepresented minority populations: American Indian/Alaska Native, Chinese, Filipino, and Asian Indian. Pediatrics 122, e217-e222 (2008).
43. Howard, T.D. et al. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 112 717-722 (2003).
44. Hersh, C.P. et al. Comprehensive testing of positionally cloned asthma genes in two populations. Am. J. Respir. Crit. Care Med. 176, 849-857 (2007)
45. Choudhry, S. et al. Pharmacogenetic diferences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am. J. Respir. Crit. Care Med. 171, 563-570 (2005).
46. Tsai, H.J. et al. β2-Adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum. Genet. 119, 547-557 (2006).
47. Pui, C.H. et al. treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360, 2730-2741 (2009).
48. Yang, J.J. et al. genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 301, 393-403 (2009).
49. Valdes, A.M. et al. genome-wide association scan identifes a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am. J. Hum. Genet. 82, 1231-1240 (2008).
50. Pritchard, J.K., stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945-959 (2000).
51. Mao, X. et al. A genomewide admixture mapping panel for Hispanic/Latino populations. Am. J. Hum. Genet. 80, 1171-1178 (2007).